Welcome to Xeraya Capital
At Xeraya, all of our activities, expertise, and resources focus solely on the Life Sciences sector. We look to generate superior investment returns by cultivating value over the long-term. We collaborate with and nurture our portfolio companies. We ensure that every investment we make not only delivers financial returns but brings benefits to humanity, including Malaysia and our surrounding region.
Medical Technologies
Bringing medical innovation to all.
View More
Healthcare Biotech
Reshaping medical standard of care.
View More
Bio Renewables & Bio Industrial
Creating a cleaner world for the future.
View More
Portfolio Highlights
PrIME Biologics
PrIME Biologics (PrIME) uses its revolutionary PrIME Technology to manufacture therapeutic plasma products that is currently underutilised by many emerging countries. The PrIME Technology in association with GE Healthcare based Chromatography in a process called PrIME + could potentially save many lives much of the world shortage of plasma products could be addressed could be saved. And address a market of about USD1bn...
Read more
Invendo Medical
Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology.

Invendo is focussed on an application in the diagnosis and treatment of colorectal cancers (CRC), the second leading cause of cancer death...
Read more
ConforMIS Inc.
ConforMIS, founded in 2004 and based in Bedford, Massachusetts, USA, creates personalised, patient-specific implants and disposable instrumentation utilising proprietary imaging technology. The company produces knee systems under the iUni, iDuo and iTotal brands. Each one has received FDA 510(k) clearance and carries the CE, supporting the multi-regional commercial approach...
Read more
Small Bone Innovations Inc.
The product portfolio of Small Bone Innovations Inc. (SBI), based in Morrisville, Pennsylvania, includes more than 40 devices designed specifically for small bone and joint surgery, such as thumb, wrist, finger, elbow, foot and ankle.

SBI’s product suite has a “star” among its ranks—the Scandinavian Total Ankle Replacement System (the STAR Ankle)...
Read more
News & Events
Press Release on ViroPro
February 2, 2015

PRNewswire, Viropro, Inc. (OTCBB: VPRO) today announced that its Board of Directors completed its strategic review and has begun the implementation of a restructuring designed to restore the company to financial health. Read more
Xeraya in the news: VC Surprise: First close of USD150m Biogreentech Venture Fund
January 12, 2015

Read more
Spruce Capital Partners and Xeraya Capital announced the first close of MLS Capital Fund II, L.P. at $150 million
January 7, 2015

San Francisco and Kuala Lumpur, Malaysia - January 7, 2015 - Spruce Capital Partners and Xeraya Capital today announced the first close of MLS Capital Fund II, L.P. at $150 million. MLS Capital Fund II, the successor to the $162 million Malaysian Life Sciences Capital Fund, is co-managed by Spruce Capital Partners and Xeraya Capital, which will invest the funds in a diversified portfolio of biogreentech companies at all stages of development. Read more
Passing away of Rashidan Shah, Xeraya's Investment Director
October 27, 2014

It is with profound sadness that Xeraya announces the sudden passing away of Xeraya's Investment Director, Rashidan, a cherished colleague and friend, on the Monday morning of 27th October 2014. Read more

Go to News & Event